This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Atenolol

Read time: 1 mins
Marketing start date: 21 Dec 2024
...
 

Summary of product characteristics


Effective Time

20220803

Version

9

Spl Product Data Elements

Atenolol Atenolol ATENOLOL ATENOLOL ANHYDROUS CITRIC ACID CROSCARMELLOSE SODIUM MAGNESIUM STEARATE SILICON DIOXIDE POVIDONE CELLULOSE, MICROCRYSTALLINE WHITE TO OFF- WHITE ROUND Z;65 Atenolol Atenolol ATENOLOL ATENOLOL ANHYDROUS CITRIC ACID CROSCARMELLOSE SODIUM MAGNESIUM STEARATE SILICON DIOXIDE POVIDONE CELLULOSE, MICROCRYSTALLINE WHITE TO OFF- WHITE ROUND Z;66 Atenolol Atenolol ATENOLOL ATENOLOL ANHYDROUS CITRIC ACID CROSCARMELLOSE SODIUM MAGNESIUM STEARATE SILICON DIOXIDE POVIDONE CELLULOSE, MICROCRYSTALLINE WHITE TO OFF- WHITE ROUND Z;67

Application Number

ANDA076900

Brand Name

Atenolol

Generic Name

Atenolol

Product Ndc

65841-022

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 65841-022-01 in bottles of 100 tablets Atenolol Tablets USP, 25 mg R x only 100 Tablets NDC 65841-023-01 in bottles of 100 tablets Atenolol Tablets USP, 50 mg R x only 100 Tablets NDC 65841-024-01 in bottles of 100 tablets Atenolol Tablets USP, 100 mg R x only 100 Tablets Atenolol Tablets, 25 mg Atenolol Tablets, 50 mg Atenolol Tablets, 100 mg

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.